Immune aging is a critical risk factor for the majority of complex age-related diseases. Effectively treating these requires a multi-dimensional, personalized approach to comprehensively mapping the disease ecosystem while embracing patient diversity and genetic variability.

At CelineBio, we take a multi-dimensional approach to personalized medicine, understanding that treatment efficacy is influenced by a variety of factors. Our patient-first tech-bio platform seamlessly integrates large-scale patient data, Generative AI, and novel methods to decode immune cell dysfunction. We identify synergistic protein combinations and unlock the next generation of precision medicine, at scale, by resetting immune health. Our proprietary platform has been validated across multiple disease areas, which demonstrated its potential to drive meaningful outcomes for patients with unmet medical needs.

We are on a mission to accelerate access to life-saving medicines, maximize clinical success, and transform patient outcomes for a healthy and happier life.